Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

SARS-CoV-2

Immune dysregulation in long COVID

Nature Immunology volume 25, pages 587–589 (2024)Cite this article

Subjects

Profiling of plasma proteins in individuals with COVID-19 shows that complement activation and myeloid inflammation are major pathways in the pathogenesis of long COVID and identifies distinct profiles of immune dysregulation in individuals with long COVID, highlighting the heterogeneous and diverse nature of this disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Mechanisms that could underlie the different manifestations of long COVID.

References

  1. Menges, D. et al. PloS ONE 16, e0254523 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Davis, H. E., McCorkell, L., Vogel, J. M. & Topol, E. J. Nat. Rev. Microbiol. 21, 133–146 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Liew, F. Nat. Immunol. https://doi.org/10.1038/s41590-024-01778-0 (2024).

    Article  PubMed  Google Scholar 

  4. Cervia-Hasler, C. et al. Science 383, eadg7942 (2024).

    Article  CAS  PubMed  Google Scholar 

  5. Chen, T., Gai, W.-P. & Abbott, C. A. BioMed Res. Int. 2014, e209398 (2014).

    Google Scholar 

  6. Qi, S. Y., Riviere, P. J., Trojnar, J., Junien, J.-L. & Akinsanya, K. O. Biochem. J. 373, 179–189 (2003).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Cervia, C. et al. J. Allergy Clin. Immunol. 147, 545–557.e9 (2021).

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank T. Hoch and A. Nicoletto for reading the manuscript. Funding was provided by Swiss National Science Foundation grants (4078P0-198431, 310030-200669 and 310030-212240 to O.B.).

Author information

Authors and Affiliations

  1. Department of Immunology, University of Zurich, University Hospital Zurich, Zurich, Switzerland

    Laura Ceglarek & Onur Boyman

  2. Faculty of Medicine and Faculty of Science, University of Zurich, Zurich, Switzerland

    Onur Boyman

Authors
  1. Laura Ceglarek
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Onur Boyman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Onur Boyman.

Ethics declarations

Competing interests

O.B. is listed as an inventor on a patent application (PCT/EP2023/084859) on biomarkers in long COVID. L.C. has no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ceglarek, L., Boyman, O. Immune dysregulation in long COVID. Nat Immunol 25, 587–589 (2024). https://doi.org/10.1038/s41590-024-01795-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41590-024-01795-z

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing